1-(4-(Trifluoromethyl)phenyl)propan-1-amine hydrochloride, 97%, 250mg

(2S,3S)-3-Hydroxypyrrolidine-2-carboxylic acid, 95.0%, 100mg

(2-Methyl-1-phenylpropyl)amine, 95.0%, 250mg

(S)-2-(2-Oxopyrrolidin-1-yl)butanamide, 95.0%, 500g

1,3-Bis(5-methyl-1,2,4-oxadiazolyl)benzene, 1g

4,7-Dichloro-2-methylquinazoline, 97%, 2.5g

Tazarotenic acid, 99.57%, 100mg

[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]acetic acid, 95.0%, 500mg

Mesityl Bromide>99.0%(GC)25g

2-(1-methyl-1H-pyrazol-4-yl)acetic acid hydrochloride, 95.0%, 500mg

Propylenglykolmonobutylether, min 99 %, zur Synthese, 1 l, kunststoffverpackung.

4-Nitro-1,2,3,6,7,8-hexahydropyrene>98.0%(HPLC)(N)1g

1-(2-Bromo-5-methylbenzyl)piperidine, 97%, 1g